ZA875847B - Pharmaceutical compositions for the treatment of occlusive vascular diseases - Google Patents

Pharmaceutical compositions for the treatment of occlusive vascular diseases

Info

Publication number
ZA875847B
ZA875847B ZA875847A ZA875847A ZA875847B ZA 875847 B ZA875847 B ZA 875847B ZA 875847 A ZA875847 A ZA 875847A ZA 875847 A ZA875847 A ZA 875847A ZA 875847 B ZA875847 B ZA 875847B
Authority
ZA
South Africa
Prior art keywords
treatment
pharmaceutical compositions
vascular diseases
occlusive vascular
occlusive
Prior art date
Application number
ZA875847A
Other languages
English (en)
Inventor
Paul Anthony Humphrey Patrick
Lumley Philip
Original Assignee
Glaxo Group Limited
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Glaxo Group Limited filed Critical Glaxo Group Limited
Publication of ZA875847B publication Critical patent/ZA875847B/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445—Non condensed piperidines, e.g. piperocaine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Epidemiology (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
ZA875847A 1986-08-08 1987-08-07 Pharmaceutical compositions for the treatment of occlusive vascular diseases ZA875847B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB868619450A GB8619450D0 (en) 1986-08-08 1986-08-08 Chemical compositions

Publications (1)

Publication Number Publication Date
ZA875847B true ZA875847B (en) 1988-01-17

Family

ID=10602485

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA875847A ZA875847B (en) 1986-08-08 1987-08-07 Pharmaceutical compositions for the treatment of occlusive vascular diseases

Country Status (7)

Country Link
EP (1) EP0256805A3 (fr)
JP (1) JPS6348218A (fr)
AU (1) AU605782B2 (fr)
CA (1) CA1313500C (fr)
GB (1) GB8619450D0 (fr)
NZ (1) NZ221380A (fr)
ZA (1) ZA875847B (fr)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8820578D0 (en) * 1988-08-31 1988-09-28 Glaxo Group Ltd Chemical compositions
GB8626297D0 (en) * 1986-11-04 1986-12-03 Ici Plc Pharmaceutical compositions
US5221695A (en) * 1987-12-22 1993-06-22 Glaxo Group Limited Aqueous formulation containing a piperidinylcyclopentylheptenoic acid derivative and beta-cyclodextrin
GB8805077D0 (en) * 1988-03-03 1988-03-30 Glaxo Group Ltd Pharmaceutical combinations
GB8807505D0 (en) * 1988-03-29 1988-05-05 Glaxo Group Ltd Pharmaceutical combinations
DE4031821A1 (de) * 1990-10-08 1992-04-09 Boehringer Mannheim Gmbh Verwendung von thromboxan-a2-rezeptoren-antagonisten gegen proliferative veraenderungen in der gefaesswand
EP3553477B1 (fr) 2018-04-13 2020-10-14 Ontech Security, S.L. Appareil de mesure de perturbation dans un champ magnétique contrôlé
EP4212890A1 (fr) 2022-01-17 2023-07-19 Ontech Security, SL Méthode et dispositif pour mesurer les perturbations dans un champ électromagnétique contrôlé
EP4213121A1 (fr) 2022-01-17 2023-07-19 Ontech Security, SL Méthode et dispositif pour mesurer les perturbations dans un champ électromagnétique contrôlé

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB2127406B (en) * 1982-09-16 1986-03-05 Glaxo Group Ltd Piperidinlycyclopentanolheptenoic acid salt

Also Published As

Publication number Publication date
AU7670687A (en) 1988-02-11
CA1313500C (fr) 1993-02-09
GB8619450D0 (en) 1986-09-17
EP0256805A3 (fr) 1990-01-10
JPS6348218A (ja) 1988-02-29
NZ221380A (en) 1990-07-26
EP0256805A2 (fr) 1988-02-24
AU605782B2 (en) 1991-01-24

Similar Documents

Publication Publication Date Title
EP0243002A3 (en) Pharmaceutical composition for the treatment of periodontal diseases
GB2188844B (en) Pharmaceutical composition for the treatment of psoriasis
IL76591A (en) Pharmaceutical compositions containing ifn-ypsilon for the treatment or prevention of malignant or viral diseases
IL86423A0 (en) Pharmaceutical compositions for the treatment of alzheimer's disease
IL76561A (en) Pharmaceutical compositions containing ifn-ypsilon for the treatment of rheumatic diseases
ZA875847B (en) Pharmaceutical compositions for the treatment of occlusive vascular diseases
DE3261760D1 (en) Pharmaceutical compositions for the treatment of skin
BG49522A1 (en) Pharmaceutist composition accelarating the healing of mounds
GB2105992B (en) Pharmaceutical composition for treatment of cardio-vascular diseases
GB2204488B (en) Pharmaceutical compositions for the treatment or prophylaxis of skin disorders
IL93242A0 (en) Pharmaceutical preparation for the treatment of tonsillitis
EP0343671A3 (en) Pharmaceutical composition for the treatment of skin wounds
AU1541088A (en) Composition for the treatment of the epiderm
IL96455A0 (en) Pharmaceutical compositions for the treatment of hsv
AP9000180A0 (en) Pharmaceutical composition for the treatment of protozoal diseases
IL84012A0 (en) Pharmaceutical composition for the treatment of high blood pressure
IL89431A0 (en) Pharmaceutical compositions for the treatment of autoimmune diseases
IL89057A0 (en) Pharmaceutical compositions for the treatment of ulcers containing quinoline or benzodiazine derivatives
IE872117L (en) Treatment of occlusive vascular diseases
ZA935120B (en) Medicinal compositions for the improvement of blood coagulation comprising TCF-II
GB9010389D0 (en) Pharmaceutical formulations for the treatment of peripheral vascular diseases
HU895239D0 (en) Process for the preparation of pharmaceutical compositions suitable for the treatment of skin diseases
IL82293A0 (en) Pharmaceutical compositions for the treatment of malaria
IL82376A (en) Pharmaceutical composition for the treatment of inflammatory conditions
GB8709861D0 (en) Pharmaceutical compositions & treatment